Archive: Company News
Company News: Curetis Publishes Business and Financial Update for the First Nine Months of 2017
– Preparing for expected U.S. FDA clearance decision on Unyvero System and Unyvero LRT Application
– Second U.S. FDA trial initiated for Unyvero IJI Application
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today published a business and financial update for the first nine months ended September 30, 2017, and provided details on its outlook for the coming months.
akampion hosts expert panel at BIO-Europe 2017, co-authors scientific article in Human Gene Therapy
akampion to host expert panel on successful corporate communications at BIO-Europe 2017
We are happy to announce that akampion is a silver sponsor of this year’s BIO-Europe in Berlin and will host an expert panel on successful corporate communications in a changing media and investment world. The discussion will focus on the needs of both healthcare-savvy media / investors and generalists and how companies can address these needs.
Company News: Prof. Dr. Cornelis Melief Receives Honorary Doctorate from Johannes Gutenberg University Mainz
— Ceremony Conventio Medicinae held at University Medical Center
ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that its Chief Scientific Officer, Prof. Cornelis Melief, has received an honorary doctorate from the University Medical Center of Johannes Gutenberg University Mainz, Germany. The honorary doctorate was awarded during a festive ceremony in Mainz on October 25, 2017.
Company News: Curetis initiates U.S. FDA study for Unyvero Invasive Joint Infections Cartridge
— Initial patient samples collected for second U.S. Unyvero Product Study
— Prospective clinical trial expected to start in 2018
Curetis N.V. (the “Company” together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced it has started collecting patient samples for a multi center FDA study for its Unyvero IJI Cartridge for the detection of invasive joint infections.